It is still controversial whether intrinsic
interferon (IFN)-gamma promotes or attenuates
vascular remodeling in hyperproliferative vascular disorders, such as
neointima formation after balloon injury. Thus, we investigated whether inhibition of intrinsic IFN-gamma function prevents
neointima formation. For this purpose, naked
DNA plasmid encoding a soluble mutant of IFN-gamma receptor alpha-subunit (sIFNgammaR; an IFN-gamma inhibitory
protein) or mock plasmid was injected into the thigh muscle of male Wistar rats 2 days before balloon injury (day -2). sIFNgammaR gene transfer significantly elevated serum levels of sIFNgammaR
protein for 2 weeks. In mock-treated rats, balloon injury induced smooth muscle cell proliferation in the
neointima with a peak at day 7 and produced thick
neointima at day 14. sIFNgammaR treatment reduced the number of proliferating intimal smooth muscle cells by 50% at day 7 and attenuated
neointima formation with a 45% reduction of the intima/media area ratio at day 14. In mock-treated rats, at day 7, balloon injury induced phosphorylation of signal transducer and activator of transcription-1 and upregulations of IFN regulatory factor-1 (a
transcription factor mediating IFN-gamma signal). Balloon injury also upregulated the key molecules of
neointima formation, such as
intercellular adhesion molecule-1 and
platelet-derived growth factor beta-receptor. These changes were suppressed by sIFNgammaR treatment. In conclusion, it is suggested that intrinsic IFN-gamma promotes
neointima formation probably through IFN regulatory factor-1/intercellular adhesion molecule-1-mediated and
platelet-derived growth factor-mediated mechanisms. Thus, inhibition of IFN-gamma signaling may be a new therapeutic target for prevention of
neointima formation of hyperproliferative vascular disorders.